EUR 15.35
(3.02%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 45.96 Million EUR | 387.67% |
2022 | 9.36 Million EUR | -57.2% |
2021 | 21.5 Million EUR | -6.03% |
2020 | 22.82 Million EUR | 4.96% |
2019 | 21.73 Million EUR | 21.17% |
2018 | 17.96 Million EUR | 37.37% |
2017 | 13.38 Million EUR | 11.92% |
2016 | 11.69 Million EUR | 53.09% |
2015 | 7.57 Million EUR | 24.34% |
2014 | 6.08 Million EUR | -27.44% |
2013 | 8.37 Million EUR | -6.13% |
2012 | 8.96 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 19.69 Million EUR | 95.22% |
2024 Q1 | 10.01 Million EUR | 158.93% |
2023 Q2 | 19.09 Million EUR | 94.83% |
2023 Q1 | 9.79 Million EUR | 535.06% |
2023 FY | - EUR | 387.67% |
2023 Q3 | 13.09 Million EUR | -31.42% |
2023 Q4 | 3.38 Million EUR | -74.12% |
2022 Q3 | 3.83 Million EUR | -34.33% |
2022 Q2 | 5.83 Million EUR | 217.5% |
2022 Q1 | 1.83 Million EUR | 241.88% |
2022 FY | - EUR | -57.2% |
2022 Q4 | -2.25 Million EUR | -158.76% |
2021 FY | - EUR | -6.03% |
2021 Q4 | -1.29 Million EUR | -116.76% |
2021 Q3 | 7.73 Million EUR | -24.3% |
2021 Q1 | 4.64 Million EUR | 383.4% |
2021 Q2 | 10.21 Million EUR | 119.97% |
2020 FY | - EUR | 4.96% |
2020 Q1 | 4.58 Million EUR | 241.97% |
2020 Q2 | 9.43 Million EUR | 105.69% |
2020 Q3 | 7.68 Million EUR | -18.56% |
2020 Q4 | 960.72 Thousand EUR | -87.5% |
2019 Q3 | 7.77 Million EUR | -6.94% |
2019 FY | - EUR | 21.17% |
2019 Q2 | 8.35 Million EUR | 103.32% |
2019 Q4 | 1.34 Million EUR | -82.76% |
2019 Q1 | 4.11 Million EUR | 2630.24% |
2018 FY | - EUR | 37.37% |
2018 Q2 | 8.97 Million EUR | 197.23% |
2018 Q4 | 150.59 Thousand EUR | -97.35% |
2018 Q1 | 3.01 Million EUR | 2008.88% |
2018 Q3 | 5.67 Million EUR | -36.77% |
2017 Q2 | 6.02 Million EUR | 156.95% |
2017 Q3 | 4.75 Million EUR | -21.16% |
2017 Q4 | -158.18 Thousand EUR | -103.33% |
2017 FY | - EUR | 11.92% |
2017 Q1 | 2.34 Million EUR | 7.72% |
2016 Q1 | 3.11 Million EUR | 173.95% |
2016 FY | - EUR | 53.09% |
2016 Q3 | 2.17 Million EUR | -29.97% |
2016 Q4 | 2.17 Million EUR | 0.0% |
2016 Q2 | 3.11 Million EUR | -0.0% |
2015 FY | - EUR | 24.34% |
2015 Q4 | -4.2 Million EUR | -175.35% |
2015 Q3 | 5.58 Million EUR | 14.31% |
2015 Q2 | 4.88 Million EUR | 251.42% |
2015 Q1 | 1.38 Million EUR | 224.7% |
2014 Q4 | -1.11 Million EUR | -130.85% |
2014 FY | - EUR | -27.44% |
2014 Q3 | 3.61 Million EUR | 16.64% |
2014 Q2 | 3.09 Million EUR | 255.82% |
2014 Q1 | 870.52 Thousand EUR | 144.08% |
2013 Q3 | 4.08 Million EUR | -19.6% |
2013 Q4 | -1.97 Million EUR | -148.37% |
2013 FY | - EUR | -6.13% |
2013 Q1 | 1.13 Million EUR | 186.41% |
2013 Q2 | 5.07 Million EUR | 347.24% |
2012 FY | - EUR | 0.0% |
2012 Q1 | 924.21 Thousand EUR | 0.0% |
2012 Q3 | 4.23 Million EUR | -20.84% |
2012 Q4 | -1.31 Million EUR | -131.01% |
2012 Q2 | 5.35 Million EUR | 479.13% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Evrofarma SA | 5.31 Million EUR | -765.238% |
Flour Mills Kepenos S.A. | 3.64 Million EUR | -1160.279% |
Loulis Food Ingredients S.A. | 19.85 Million EUR | -131.489% |